Latest News

GeoVax Media and Presentation Update
Zika Vaccine Development Discussed in February Issue of PharmaVoice Upcoming Scientific Presentatio...
Continue Reading...
GeoVax Announces Initiation of HIV Human Clinical Trial
GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today ...
Continue Reading...
GeoVax to Collaborate with Georgia State University On Development of Therapeutic Hepatitis B Vaccine
Targeting Chronic Hepatitis B Infections Affecting More Than 240 Million People Worldwide GeoVax La...
Continue Reading...